Literature DB >> 8444467

A null allele frequent in non-Jewish Tay-Sachs patients.

S Akli1, J Chelly, A Kahn, L Poenaru.   

Abstract

The molecular basis of null alleles was investigated by cDNA polymerase chain reaction (PCR) in seven Tay-Sachs patients. Although mRNAs were undetectable by Northern blot, cDNA-PCR amplification allowed us to get a sufficient amount of cDNA to characterize abnormal transcripts. In two French patients (one homozygote and one compound heterozygote with a 4-bp insertion in exon 11 of the second allele) suffering an infantile form of the disease, we detected abnormal RNAs with a 17-bp insertion due to a GT to AT transition at the donor site of intron 9, resulting in the activation of a cryptic donor site in the intron. This mutation has been found in 9 out of 82 Tay-Sachs chromosomes (11%) in association with alleles responsible from different clinical courses. In the other five patients we found the 4-bp insertion in exon 11 and two nonsense mutations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444467     DOI: 10.1007/bf00202478

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

1.  A deletion involving Alu sequences in the beta-hexosaminidase alpha-chain gene of French Canadians with Tay-Sachs disease.

Authors:  R Myerowitz; N D Hogikyan
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

2.  A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.

Authors:  S Akli; J Chelly; C Mezard; S Gandy; A Kahn; L Poenaru
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

3.  Exon definition may facilitate splice site selection in RNAs with multiple exons.

Authors:  B L Robberson; G J Cote; S M Berget
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

4.  An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide.

Authors:  P R Winship
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

5.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression.

Authors:  M B Shapiro; P Senapathy
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

6.  mRNA phenotyping by enzymatic amplification of randomly primed cDNA.

Authors:  K E Noonan; I B Roninson
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

7.  Scanning from an independently specified branch point defines the 3' splice site of mammalian introns.

Authors:  C W Smith; E B Porro; J G Patton; B Nadal-Ginard
Journal:  Nature       Date:  1989-11-16       Impact factor: 49.962

8.  The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.

Authors:  R Myerowitz; F C Costigan
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

9.  Organization of the gene encoding the human beta-hexosaminidase alpha-chain.

Authors:  R L Proia; E Soravia
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

10.  Mutagenic deamination of cytosine residues in DNA.

Authors:  B K Duncan; J H Miller
Journal:  Nature       Date:  1980-10-09       Impact factor: 49.962

View more
  3 in total

1.  Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain.

Authors:  M van Bael; M R Natowicz; J Tomczak; E E Grebner; E M Prence
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

2.  Further investigation of the HEXA gene intron 9 donor splice site mutation frequently found in non-Jewish Tay-Sachs disease patients from the British Isles.

Authors:  E C Landels; P M Green; I H Ellis; A H Fensom; M M Kaback; J Lim-Steele; K Zeiger; N Levy; M Bobrow
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

3.  Intrinsic differences between authentic and cryptic 5' splice sites.

Authors:  Xavier Roca; Ravi Sachidanandam; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.